Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Understanding Lung Cancer Resources and Barriers Among Worksites With Mostly Male Employees in Eight Rural Kentucky Counties: A Focus Group Discussion.

Knight JR, Williamson LH, Armstrong DK, Westbrook EA.

Am J Mens Health. 2019 Nov-Dec;13(6):1557988319882585. doi: 10.1177/1557988319882585.

2.

Nanoparticle assisted nuclear relaxation-based oligonucleotide detection.

Silva RN, Vijayan AN, Westbrook E, Yu Z, Zhang P.

Anal Chim Acta. 2019 Jul 25;1062:118-123. doi: 10.1016/j.aca.2019.02.029. Epub 2019 Feb 25.

PMID:
30947987
3.

Plasmon-enhanced triplet-triplet annihilation upconversion of post-modified polymeric acceptors.

Westbrook EG, Zhang P.

Dalton Trans. 2018 Jul 14;47(26):8638-8645. doi: 10.1039/c8dt00269j. Epub 2018 Mar 15.

PMID:
29541706
4.

Acidotoxicity via ASIC1a Mediates Cell Death during Oxygen Glucose Deprivation and Abolishes Excitotoxicity.

Bhowmick S, Moore JT, Kirschner DL, Curry MC, Westbrook EG, Rasley BT, Drew KL.

ACS Chem Neurosci. 2017 Jun 21;8(6):1204-1212. doi: 10.1021/acschemneuro.6b00355. Epub 2017 Mar 1.

5.

Exploring Provider Reactions to Decision Aid Distribution and Shared Decision Making: Lessons from Two Specialties.

Hsu C, Liss DT, Frosch DL, Westbrook EO, Arterburn D.

Med Decis Making. 2017 Jan;37(1):113-126. Epub 2016 Oct 6.

PMID:
27899745
6.

Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation.

Kratz M, Hagman DK, Kuzma JN, Foster-Schubert KE, Chan CP, Stewart S, van Yserloo B, Westbrook EO, Arterburn DE, Flum DR, Cummings DE.

Obesity (Silver Spring). 2016 Jul;24(7):1438-45. doi: 10.1002/oby.21524. Epub 2016 May 26.

7.

Long-Term Weight Change after Initiating Second-Generation Antidepressants.

Arterburn D, Sofer T, Boudreau DM, Bogart A, Westbrook EO, Theis MK, Simon G, Haneuse S.

J Clin Med. 2016 Apr 13;5(4). pii: E48. doi: 10.3390/jcm5040048.

8.

Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial.

Cummings DE, Arterburn DE, Westbrook EO, Kuzma JN, Stewart SD, Chan CP, Bock SN, Landers JT, Kratz M, Foster-Schubert KE, Flum DR.

Diabetologia. 2016 May;59(5):945-53. doi: 10.1007/s00125-016-3903-x. Epub 2016 Mar 17.

9.

Learning About Missing Data Mechanisms in Electronic Health Records-based Research: A Survey-based Approach.

Haneuse S, Bogart A, Jazic I, Westbrook EO, Boudreau D, Theis MK, Simon GE, Arterburn D.

Epidemiology. 2016 Jan;27(1):82-90. doi: 10.1097/EDE.0000000000000393.

10.

Antipsychotic medications and extreme weight gain in two health systems.

Arterburn D, Wood GC, Theis MK, Westbrook EO, Anau J, Rukstalis M, Boscarino JA, Daar Z, Gerhard GS.

Obes Res Clin Pract. 2016 Jul-Aug;10(4):408-23. doi: 10.1016/j.orcp.2015.08.012. Epub 2015 Sep 8.

PMID:
26361961
11.

Decision aids for benign prostatic hyperplasia and prostate cancer.

Arterburn D, Wellman R, Westbrook EO, Ross TR, McCulloch D, Handley M, Lowe M, Cable C, Zeliadt SB, Hoffman RM.

Am J Manag Care. 2015 Feb 1;21(2):e130-40.

12.

Viewing condition dependence of the gaze-evoked nystagmus in Arnold Chiari type 1 malformation.

Ghasia FF, Gulati D, Westbrook EL, Shaikh AG.

J Neurol Sci. 2014 Apr 15;339(1-2):134-9. doi: 10.1016/j.jns.2014.01.045. Epub 2014 Feb 11.

PMID:
24559612
13.

A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes.

Arterburn D, Flum DR, Westbrook EO, Fuller S, Shea M, Bock SN, Landers J, Kowalski K, Turnbull E, Cummings DE; CROSSROADS Study Team.

Surg Obes Relat Dis. 2013 Nov-Dec;9(6):837-44. doi: 10.1016/j.soard.2013.05.006. Epub 2013 Jun 4.

14.

Weight control practices of severely obese patients who are not seeking bariatric surgery.

Arterburn D, Westbrook EO, Terrell A.

Obesity (Silver Spring). 2013 Aug;21(8):1509-13. doi: 10.1002/oby.20488. Epub 2013 Jul 5.

15.

Influence of body mass index on the choice of therapy for depression and follow-up care.

Boudreau DM, Arterburn D, Bogart A, Haneuse S, Theis MK, Westbrook E, Simon G.

Obesity (Silver Spring). 2013 Mar;21(3):E303-13. doi: 10.1002/oby.20048.

16.

Incorporating patient decision aids into standard clinical practice in an integrated delivery system.

Hsu C, Liss DT, Westbrook EO, Arterburn D.

Med Decis Making. 2013 Jan;33(1):85-97. doi: 10.1177/0272989X12468615.

PMID:
23300204
17.

Introducing decision aids at Group Health was linked to sharply lower hip and knee surgery rates and costs.

Arterburn D, Wellman R, Westbrook E, Rutter C, Ross T, McCulloch D, Handley M, Jung C.

Health Aff (Millwood). 2012 Sep;31(9):2094-104. doi: 10.1377/hlthaff.2011.0686.

PMID:
22949460
18.

Relationship between Obesity, Depression, and Disability in Middle-Aged Women.

Arterburn D, Westbrook EO, Ludman EJ, Operskalski B, Linde JA, Rohde P, Jeffery RW, Simon GE.

Obes Res Clin Pract. 2012 Jul;6(3):e197-e206. Epub 2012 Mar 3.

19.

Questions about quitting (Q2): design and methods of a Multiphase Optimization Strategy (MOST) randomized screening experiment for an online, motivational smoking cessation intervention.

McClure JB, Derry H, Riggs KR, Westbrook EW, St John J, Shortreed SM, Bogart A, An LC.

Contemp Clin Trials. 2012 Sep;33(5):1094-102. doi: 10.1016/j.cct.2012.06.009. Epub 2012 Jul 4. Erratum in: Contemp Clin Trials. 2013 May;35(1):179-80.

20.

Relationship between obesity, depression, and disability in middle-aged women.

Arterburn D, Westbrook EO, Ludman EJ, Operskalski B, Linde JA, Rohde P, Jeffery RW, Simon GE.

Obes Res Clin Pract. 2012 Jul-Sep;6(3):e175-262. doi: 10.1016/j.orcp.2012.02.007.

PMID:
24331522
21.

Randomized trial of a video-based patient decision aid for bariatric surgery.

Arterburn DE, Westbrook EO, Bogart TA, Sepucha KR, Bock SN, Weppner WG.

Obesity (Silver Spring). 2011 Aug;19(8):1669-75. doi: 10.1038/oby.2011.65. Epub 2011 Apr 7.

22.

Using microscopy to assess chorion structural integrity and parasitoid oviposition sites on stink bug (Hemiptera: Pentatomidae) eggs.

Koppel AL, Herbert DA Jr, Westbrook EW.

Microsc Microanal. 2011 Feb;17(1):114-7. doi: 10.1017/S1431927610093906. Epub 2010 Oct 4.

PMID:
20920377
23.

Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial.

McClure JB, Jack L, Deprey M, Catz S, McAfee T, Zbikowski S, Westbrook E, Swan G.

Nicotine Tob Res. 2008 Dec;10(12):1815-6. doi: 10.1080/14622200802488358. No abstract available.

PMID:
19023832
24.

Insurance coverage and incentives for weight loss among adults with metabolic syndrome.

Arterburn D, Westbrook EO, Wiese CJ, Ludman EJ, Grossman DC, Fishman PA, Finkelstein EA, Jeffery RW, Drewnowski A.

Obesity (Silver Spring). 2008 Jan;16(1):70-6. doi: 10.1038/oby.2007.18.

25.

Active-edge planar radiation sensors.

Kenney CJ, Segal JD, Westbrook E, Parker S, Hasi J, Da Via C, Watts S, Morse J.

Nucl Instrum Methods Phys Res A. 2006 Sep 1;565(1):272-277.

26.

Lens-Coupled CCD Detector for X-ray Crystallography.

Madden TJ, McGuigan W, Molitsky MJ, Naday I, McArthur A, Westbrook EM.

IEEE Trans Nucl Sci. 2006 Nov 1;2:729-734.

27.

Research letter: Using a commercial mailing list to recruit smokers: a cautionary tale.

McClure JB, Richards J, Westbrook EO, Pabiniak C, Ludman E.

Am J Prev Med. 2007 Nov;33(5):436-7. No abstract available.

PMID:
17950411
28.

The Structural Biology Center 19ID undulator beamline: facility specifications and protein crystallographic results.

Rosenbaum G, Alkire RW, Evans G, Rotella FJ, Lazarski K, Zhang RG, Ginell SL, Duke N, Naday I, Lazarz J, Molitsky MJ, Keefe L, Gonczy J, Rock L, Sanishvili R, Walsh MA, Westbrook E, Joachimiak A.

J Synchrotron Radiat. 2006 Jan;13(Pt 1):30-45. Epub 2005 Dec 22.

29.

Structure of the Escherichia coli FlhDC complex, a prokaryotic heteromeric regulator of transcription.

Wang S, Fleming RT, Westbrook EM, Matsumura P, McKay DB.

J Mol Biol. 2006 Jan 27;355(4):798-808. Epub 2005 Nov 22.

PMID:
16337229
30.

Proactive, motivationally enhanced smoking cessation counseling among women with elevated cervical cancer risk.

McClure JB, Westbrook E, Curry SJ, Wetter DW.

Nicotine Tob Res. 2005 Dec;7(6):881-9.

PMID:
16298723
31.

Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer.

Weinmann S, Taplin SH, Gilbert J, Beverly RK, Geiger AM, Yood MU, Mouchawar J, Manos MM, Zapka JG, Westbrook E, Barlow WE.

J Natl Cancer Inst Monogr. 2005;(35):33-8.

PMID:
16287883
32.

Re: Breast cancer screening comes full circle.

Taplin SH, Barlow WE, Ulcickas-Yood M, Westbrook E, Geiger AM, Bischoff K, Ichikawa L.

J Natl Cancer Inst. 2005 Mar 16;97(6):461. No abstract available.

PMID:
15770012
33.

Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?

Taplin SH, Ichikawa L, Yood MU, Manos MM, Geiger AM, Weinmann S, Gilbert J, Mouchawar J, Leyden WA, Altaras R, Beverly RK, Casso D, Westbrook EO, Bischoff K, Zapka JG, Barlow WE.

J Natl Cancer Inst. 2004 Oct 20;96(20):1518-27.

PMID:
15494602
34.

Structure of the constitutively active double mutant CheYD13K Y106W alone and in complex with a FliM peptide.

Dyer CM, Quillin ML, Campos A, Lu J, McEvoy MM, Hausrath AC, Westbrook EM, Matsumura P, Matthews BW, Dahlquist FW.

J Mol Biol. 2004 Sep 24;342(4):1325-35.

PMID:
15351654
35.

The laccase gene family in Coprinopsis cinerea (Coprinus cinereus).

Hoegger PJ, Navarro-González M, Kilaru S, Hoffmann M, Westbrook ED, Kües U.

Curr Genet. 2004 Feb;45(1):9-18. Epub 2003 Nov 5.

PMID:
14600788
36.

Practice parameter: temporal lobe and localized neocortical resections for epilepsy.

Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, Gumnit R, Zahn C, Westbrook E, Enos B.

Epilepsia. 2003 Jun;44(6):741-51. Review.

37.

Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons.

Engel J Jr, Wiebe S, French J, Sperling M, Williamson P, Spencer D, Gumnit R, Zahn C, Westbrook E, Enos B; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society; American Association of Neurological Surgeons.

Neurology. 2003 Feb 25;60(4):538-47. Review. Erratum in: Neurology. 2003 Apr 22;60(8):1396.

PMID:
12601090
38.

Prednisone eliminates the electrophysiological decrement of myotonia congenita.

Chelimsky T, Neal P, Westbrook E.

J Clin Neuromuscul Dis. 2002 Dec;4(2):75-7.

PMID:
19078693
39.

Crystallization and preliminary X-ray crystallographic analysis of FlhD/FlhC complex from Escherichia coli.

Wang S, Matsumura P, Westbrook EM.

Acta Crystallogr D Biol Crystallogr. 2001 May;57(Pt 5):734-6. Epub 2001 Apr 24.

PMID:
11320321
40.

Crystal structure of the global regulator FlhD from Escherichia coli at 1.8 A resolution.

Campos A, Zhang RG, Alkire RW, Matsumura P, Westbrook EM.

Mol Microbiol. 2001 Feb;39(3):567-80.

41.

Differential signatures of bacterial and mammalian IMP dehydrogenase enzymes.

Zhang R, Evans G, Rotella F, Westbrook E, Huberman E, Joachimiak A, Collart FR.

Curr Med Chem. 1999 Jul;6(7):537-43.

PMID:
10390599
42.

Avian species differences in susceptibility to noise exposure.

Ryals BM, Dooling RJ, Westbrook E, Dent ML, MacKenzie A, Larsen ON.

Hear Res. 1999 May;131(1-2):71-88.

PMID:
10355606
43.

Characteristics and crystal structure of bacterial inosine-5'-monophosphate dehydrogenase.

Zhang R, Evans G, Rotella FJ, Westbrook EM, Beno D, Huberman E, Joachimiak A, Collart FR.

Biochemistry. 1999 Apr 13;38(15):4691-700.

PMID:
10200156
44.

Effects of columella removal on inner ear morphology in the chick.

Code RA, Westbrook EW, Ryals BM.

Hear Res. 1998 Dec;126(1-2):113-22.

PMID:
9872139
45.

Morphological evidence of ototoxicity of the iron chelator deferoxamine.

Ryals B, Westbrook E, Schacht J.

Hear Res. 1997 Oct;112(1-2):44-8.

PMID:
9367228
46.

MAD analysis of FHIT, a putative human tumor suppressor from the HIT protein family.

Lima CD, D'Amico KL, Naday I, Rosenbaum G, Westbrook EM, Hendrickson WA.

Structure. 1997 Jun 15;5(6):763-74.

47.

[17] Charge-coupled device-based area detectors.

Westbrook EM, Naday I.

Methods Enzymol. 1997;276:244-268. doi: 10.1016/S0076-6879(97)76063-4. No abstract available.

PMID:
27799099
48.

Charge-coupled device-based area detectors.

Westbrook EM, Naday I.

Methods Enzymol. 1997;276:244-68. No abstract available.

PMID:
9048377
49.

The three-dimensional crystal structure of cholera toxin.

Zhang RG, Scott DL, Westbrook ML, Nance S, Spangler BD, Shipley GG, Westbrook EM.

J Mol Biol. 1995 Aug 25;251(4):563-73.

PMID:
7658473
50.

The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid.

Zhang RG, Westbrook ML, Westbrook EM, Scott DL, Otwinowski Z, Maulik PR, Reed RA, Shipley GG.

J Mol Biol. 1995 Aug 25;251(4):550-62.

PMID:
7658472

Supplemental Content

Loading ...
Support Center